0.00Open1.30Pre Close0 Volume2 Open Interest140.00Strike Price0.00Turnover796.76%IV28.21%PremiumApr 17, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry1.30Extrinsic Value100Contract SizeAmericanOptions Type0.1305Delta0.0098Gamma84.78Leverage Ratio-10.2319Theta0.0001Rho11.06Eff Leverage0.0057Vega
Novartis AG Stock Discussion
Gapping Up
$MSP Recovery (MSPR.US)$ shares surged 125% after the company announced a strategic term sheet aimed at enhancing liquidity and restructuring current agreements. This move will eliminate over $1.2 billion in corporate guaranteed debt and includes new agreements designed to propel future growth.
$JPMorgan (JPM.US)$ climbed 3.8% in premarket trading on Friday after the bank reported a quarterly profit increa...
Groundbreaking FDA Approval: Novartis Drug Shows 36% Reduction in Severe Kidney Disease Symptoms
Breakthrough: Novartis Scores Historic FDA Approval for Rare Kidney Disease Treatment
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
No comment yet